BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

176 related articles for article (PubMed ID: 37014368)

  • 21. Administration of activated glial condition medium in the nucleus accumbens extended extinction and intensified reinstatement of methamphetamine-induced conditioned place preference.
    Arezoomandan R; Moradi M; Attarzadeh-Yazdi G; Tomaz C; Haghparast A
    Brain Res Bull; 2016 Jul; 125():106-16. PubMed ID: 27346277
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Psilocin suppresses methamphetamine-induced hyperlocomotion and acquisition of conditioned place preference via D2R-mediated ERK signaling.
    Wang J; Liang M; Shang Q; Qian H; An R; Liu H; Shao G; Li T; Liu X
    CNS Neurosci Ther; 2023 Mar; 29(3):831-841. PubMed ID: 36627756
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Levo-tetrahydropalmatine attenuates methamphetamine reward behavior and the accompanying activation of ERK phosphorylation in mice.
    Su H; Sun T; Wang X; Du Y; Zhao N; Zhu J; Yan J; Chen T; Yun K
    Neurosci Lett; 2020 Jan; 714():134416. PubMed ID: 31398456
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The distinct roles of various neurotransmitters in modulating methamphetamine-induced conditioned place preference in relevant brain regions in mice.
    Su H; Bai J; Fan Y; Sun T; Du Y; Li Y; Wei Z; Chen T; Guo X; Yun K
    Neuroreport; 2022 Feb; 33(3):101-108. PubMed ID: 34966126
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Inhibition of vesicular glutamate transporters contributes to attenuate methamphetamine-induced conditioned place preference in rats.
    He Z; Chen Y; Dong H; Su R; Gong Z; Yan L
    Behav Brain Res; 2014 Jul; 267():1-5. PubMed ID: 24613241
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A novel molecule "shati" is involved in methamphetamine-induced hyperlocomotion, sensitization, and conditioned place preference.
    Niwa M; Nitta A; Mizoguchi H; Ito Y; Noda Y; Nagai T; Nabeshima T
    J Neurosci; 2007 Jul; 27(28):7604-15. PubMed ID: 17626222
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The role of thioredoxin-1 in resisting methamphetamine-induced rewarding effect.
    Huang M; Kong L; Yang L; Li X; Zhou X; Li Y; Bai J
    Behav Brain Res; 2018 Jan; 337():280-286. PubMed ID: 28782589
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Absence of methamphetamine-induced conditioned place preference in weaver mutant mice.
    Ikekubo Y; Ide S; Hagino Y; Ikeda K
    Neuropsychopharmacol Rep; 2020 Dec; 40(4):324-331. PubMed ID: 32812711
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Levo-tetrahydropalmatine attenuates the development and expression of methamphetamine-induced locomotor sensitization and the accompanying activation of ERK in the nucleus accumbens and caudate putamen in mice.
    Zhao N; Chen Y; Zhu J; Wang L; Cao G; Dang Y; Yan C; Wang J; Chen T
    Neuroscience; 2014 Jan; 258():101-10. PubMed ID: 24269936
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Behavioural and biochemical responses to methamphetamine are differentially regulated by mGlu2 and mGlu3 metabotropic glutamate receptors in male mice.
    Busceti CL; Ginerete RP; Di Menna L; D'Errico G; Cisani F; Di Pietro P; Imbriglio T; Bruno V; Battaglia G; Fornai F; Monn JA; Pittaluga A; Nicoletti F
    Neuropharmacology; 2021 Sep; 196():108692. PubMed ID: 34217776
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Role of serine racemase in behavioral sensitization in mice after repeated administration of methamphetamine.
    Horio M; Kohno M; Fujita Y; Ishima T; Inoue R; Mori H; Hashimoto K
    PLoS One; 2012; 7(4):e35494. PubMed ID: 22530033
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Oxytocin treatment in the prelimbic cortex reduces relapse to methamphetamine-seeking and is associated with reduced activity in the rostral nucleus accumbens core.
    Everett N; Baracz S; Cornish J
    Pharmacol Biochem Behav; 2019 Aug; 183():64-71. PubMed ID: 31202809
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Regulation of miR-128 in the nucleus accumbens affects methamphetamine-induced behavioral sensitization by modulating proteins involved in neuroplasticity.
    Li J; Zhu L; Su H; Liu D; Yan Z; Ni T; Wei H; Goh ELK; Chen T
    Addict Biol; 2021 Jan; 26(1):e12881. PubMed ID: 32058631
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Alleviation of Methamphetamine Sensitization by Partially Lesioning Dopaminergic Terminals with 6-Hydroxydopamine in Nucleus Accumbens.
    Chen SC; Chen H; Yu SJ; Chen YH; Wang Y
    Cell Transplant; 2021; 30():9636897211052300. PubMed ID: 34743572
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The Role of HINT1 in Methamphetamine-Induced Conditioned Place Preference.
    Li JP; Liu P; Lei G; Chu Z; Liu F; Shi CF; Dang YH; Chen T
    Neurotox Res; 2018 Feb; 33(2):353-361. PubMed ID: 28844119
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Brain region-selective cellular redistribution of mGlu5 but not GABA(B) receptors following methamphetamine-induced associative learning.
    Herrold AA; Voigt RM; Napier TC
    Synapse; 2011 Dec; 65(12):1333-43. PubMed ID: 21780181
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Regulation of microRNA-29c in the nucleus accumbens modulates methamphetamine -induced locomotor sensitization in mice.
    Su H; Zhu L; Li J; Wang R; Liu D; Han W; Cadet JL; Chen T
    Neuropharmacology; 2019 Apr; 148():160-168. PubMed ID: 30639389
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Reduction of methamphetamine-induced sensitization and reward in matrix metalloproteinase-2 and -9-deficient mice.
    Mizoguchi H; Yamada K; Niwa M; Mouri A; Mizuno T; Noda Y; Nitta A; Itohara S; Banno Y; Nabeshima T
    J Neurochem; 2007 Mar; 100(6):1579-88. PubMed ID: 17348864
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Neuronal activation of nucleus accumbens by local methamphetamine administration induces cognitive impairment through microglial inflammation in mice.
    Kusui Y; Izuo N; Tokuhara R; Asano T; Nitta A
    J Pharmacol Sci; 2024 Mar; 154(3):127-138. PubMed ID: 38395513
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Deletion of SHATI/NAT8L increases dopamine D1 receptor on the cell surface in the nucleus accumbens, accelerating methamphetamine dependence.
    Toriumi K; Kondo M; Nagai T; Hashimoto R; Ohi K; Song Z; Tanaka J; Mouri A; Koseki T; Yamamori H; Furukawa-Hibi Y; Mamiya T; Fukushima T; Takeda M; Nitta A; Yamada K; Nabeshima T
    Int J Neuropsychopharmacol; 2014 Mar; 17(3):443-53. PubMed ID: 24246274
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.